30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

2Q14 Revenue: DJO

$313.9MM, +6%

  • Bracing/Vascular $128.3MM, +8%
  • Recovery Sciences $75.9MM, -2%
  • International $84.6MM, +8%
  • Surgical Implant $25.1MM, +17%)

Bracing and Vascular includes products serving the diabetes market.


  • Bracing and Vascular supported by new products, improved sales execution
  • Recovery Sciences starting to “bounce back” from the impact of Medicare’s 2012 non-coverage decision re Transcutaneous Electrical Nerve Stimulation for chronic low back pain
  • Launch of numerous MotionCare products will expected to support improved future sales in that segment